Evaluation of a New Regional Organization to Promote Access to Renal Transplantation
TRACE
Promoting Access to Renal Transplantation: Impact of a Patient-centered Regional Organization
1 other identifier
observational
4,000
1 country
1
Brief Summary
Patients with terminal chronic kidney disease (CRD) need renal function supplementation, namely dialysis or renal transplantation. Transplantation is the most efficient and cost-effective treatment. Early and equitable access to transplantation is a public health issue. Access to transplantation is facilitated by early and systematic information and assessment of patients for inclusion in the national waiting list for transplantation prior to the onset of dialysis, and by the development of transplantation from living donors. In France, there are wide disparities in access to national waiting list registration and transplantation. One of the causes of these inequalities in access would be the disparity in referral practices to a transplant medical and surgical team authorized to register the individual on the national waiting list. The aim of the TRACE study is to evaluate the impact of a new regional organization promoting renal transplantation on access to renal transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 26, 2017
CompletedFirst Posted
Study publicly available on registry
July 31, 2017
CompletedStudy Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedJanuary 29, 2020
January 1, 2020
5 years
July 26, 2017
January 27, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Cumulative incidence rate of access to renal transplantation for patients with end-stage renal failure
Access to renal transplantation is defined by: * Pre-emptive renal transplantation with living donor or deceased donor * Registration on the national waiting list for renal transplantation
At 24 months after initiation of renal function supplementation
Study Arms (2)
Control group
Patients supported without regional organization for promotion of renal transplantation Setting : French Auvergne Rhone Alpes region and French Center region
Intervention group
Patients supported with the regional organization for promotion of renal transplantation Setting : French Auvergne Rhone Alpes region
Interventions
Early identification of candidates for renal transplantation * with the help of a care coordinator Inform all patients appropriately about the techniques of renal function supplementation * delivered by expert patients and a care coordinator Assist the nephrologists in patient graft pathway * Multidisciplinary assessment of patients in dedicated web-conferencing meetings bringing together nephrologists and transplant team (" WebRCP of kidney transplant orientation") * Helping to carry out the pre-graft assessments of patients by a care coordinator
Eligibility Criteria
The population participating in the study is composed of patients with a terminal Chronic Kidney Disease (CRD) requiring renal function supplementation.
You may qualify if:
- Patient older than 18 years and younger than 85 years.
- Entered in the French Network Epidemiology and Information in Nephrology register
- Renal function supplementation begun in 2013 -- 2014 (period before regional organization implementation) or in 2018 -- 2019 (period after regional organization implementation).
You may not qualify if:
- \- Patient followed in a Center of nephrology-dialysis or of Renal transplantation located outside French Auvergne Rhône Alpes or Center Regions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Transplantation, Groupement Hospitalier Edouard Herriot, Hospices Civils de Lyon
Lyon, 69003, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2017
First Posted
July 31, 2017
Study Start
January 1, 2018
Primary Completion
January 1, 2023
Study Completion
January 1, 2023
Last Updated
January 29, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share